Frequency of Subclinical Lacunar Infarcts in Ischemic Leukoaraiosis and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

References

1. ↵
   Roman GC Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260

   Abstract/FREE Full Text
2. ↵
   Babikian V, Ropper AH. Binswanger’s disease: a review. Stroke 1987;18:2–12

   FREE Full Text
3. ↵
   Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–23

   CrossRefPubMedWeb of Science
4. ↵
   Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SC, Markus HS. Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 1999;30:393–397

   Abstract/FREE Full Text
5. ↵
   Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731–739

   CrossRefPubMedWeb of Science
6. ↵
   Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452–457

   Abstract/FREE Full Text
7. ↵
   Okeda R, Arima K, Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke 2002;33:2565–2569

   Abstract/FREE Full Text
8. ↵
   Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116:1077–1094

   CrossRefPubMedWeb of Science
9. ↵
   Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis: US National MS Society Task Force. Ann Neurol 1996;39:6–16

   CrossRefPubMedWeb of Science
10. ↵
    Molyneux PD, Filippi M, Barkhof F, et al. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 1998;43:332–339

    CrossRefPubMedWeb of Science
11. ↵
    Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis: Gadolinium MRI Meta-analysis Group. Lancet 1999;353:964–969

    CrossRefPubMedWeb of Science
12. ↵
    Warach S, Gaa J, Siewert B, Wielpolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231–241

    CrossRefPubMedWeb of Science
13. ↵
    Singer MB, Chong J, Lu D, Schonewille WJ, Tuhrim S, Atlas SW. Diffusion-weighted MRI in acute subcortical infarction. Stroke 1998;29:133–136

    Abstract/FREE Full Text
14. ↵
    Choi SH, Na DL, Chung CS, Lee KH, Na DG, Adair JC. Diffusion-weighted MRI in vascular dementia. Neurology 2000;54:83–89

    Abstract/FREE Full Text
15. ↵
    Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521–1526

    CrossRefPubMedWeb of Science
16. ↵
    Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683–1689

    Abstract/FREE Full Text
17. ↵
    Joutel A, Vahedi K, Corpechot C. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511–1515

    CrossRefPubMedWeb of Science
18. ↵
    Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515–525

    CrossRefPubMedWeb of Science
19. ↵
    Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999;212:333–339

    CrossRefPubMedWeb of Science
20. ↵
    Helenius J, Soinne L, Salonen O, Kaste M, Tatlisumak T. Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke 2002;33:45–50

    Abstract/FREE Full Text
21. ↵
    O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56:628–634

    Abstract/FREE Full Text
22. ↵
    Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134–1138

    Abstract/FREE Full Text
23. ↵
    Wittes J, Lakatos E, Probstfield J. Surrogate endpoints in clinical trials: cardiovascular diseases. Stat Med 1989;8:415–425

    CrossRefPubMedWeb of Science
24. ↵
    Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113–119

    Abstract/FREE Full Text
25. ↵
    Geijer B, Lindgren A, Brockstedt S, Stahlberg F, Holtas S. Persistent high signal on diffusion-weighted MRI in the late stages of small cortical and lacunar ischaemic lesions. Neuroradiology 2001;43:115–122

    CrossRefPubMed